Proteasome inhibitor-induced cyclooxygenase-2 expression in Raw264.7 cells is potentiated by inhibition of c-Jun N-terminal kinase activation

Biochemical and Biophysical Research Communications

Volumn 342, Issue 4, 2006, Pages 1334-1340

  Woo, Kyung Jin ^a   Park, Jong Wook ^a   Kwon, Taeg Kyu ^a  

^a Keimyung University   (South Korea)

Author keywords

COX 2; COX 2 promoter; JNK; MG132; Proteasome inhibitor

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CYCLOOXYGENASE 2; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE KINASE 7; PROSTAGLANDIN E2; PROTEASOME INHIBITOR; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR;

ANIMAL CELL; ARTICLE; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME INHIBITION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; CYCLOOXYGENASE 2; CYSTEINE PROTEINASE INHIBITORS; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LEUPEPTINS; MACROPHAGES; MICE; PROTEASOME ENDOPEPTIDASE COMPLEX;

ANIMALIA;

EID: 33644912062     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.02.105     Document Type: Article

References (35)

1. A. Hershko, and A. Ciechanover The ubiquitin system Annu. Rev. Biochem. 67 1998 425 479
2. D. Kornitzer, and A. Ciechanover Modes of regulation of ubiquitin-mediated protein degradation J. Cell. Physiol. 182 2000 1 11
3. K.L. Rock, C. Gramm, L. Rothstein, K. Clark, R. Stein, L. Dick, D. Hwang, and A.L. Goldberg Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules Cell 78 1994 761 771
4. Z. Li, M. Jansen, S.R. Pierre, and M.E. Figueiredo-Pereira Neurodegeneration: linking ubiquitin/proteasome pathway impairment with inflammation Int. J. Biochem. Cell Biol. 35 2003 547 552
5. J. An, Y. Sun, M. Fisher, and M.B. Rettig Maximal apoptosis of renal cell carcinoma by the proteasome inhibitor bortezomib is nuclear factor-kappaB dependent Mol. Cancer Ther. 3 2004 727 736
6. J.G. Snyder, R. Prewitt, J. Campsen, and L.D. Britt PDTC and Mg132, inhibitors of NF-kappaB, block endotoxin induced vasodilation of isolated rat skeletal muscle arterioles Shock 17 2002 304 307
7. J.B. Sunwoo, Z. Chen, G. Dong, N. Yeh, C.C. Bancroft, E. Sausville, J. Adams, P. Elliott, and C. Van Waes Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma Clin. Cancer Res. 7 2001 1419 1428
8. T. Lawrence, D.W. Gilroy, P.R. Colville-Nash, and D.A. Willoughby Possible new role for NF-kappaB in the resolution of inflammation Nat. Med. 7 2001 1291 1297
9. W.L. Smith, D.L. DeWitt, and R.M. Garavito Cyclooxygenases: structural, cellular, and molecular biology Annu. Rev. Biochem. 69 2000 145 182
10. D.E. Griswold, and J.L. Adams Constitutive cyclooxygenase (COX-1) and inducible cyclooxygenase (COX-2): rationale for selective inhibition and progress to date Med. Res. Rev. 16 1996 181 206
11. H.R. Herschman Function and regulation of prostaglandin synthase 2 Adv. Exp. Med. Biol. 469 1999 3 8
12. R.M. Garavito, and D.L. DeWitt The cyclooxygenase isoforms: structural insights into the conversion of arachidonic acid to prostaglandins Biochim. Biophys. Acta 1441 1999 278 287
13. V. Mollace, C. Muscoli, E. Masini, S. Cuzzocrea, and D. Salvemini Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors Pharmacol. Rev. 57 2005 217 252
14. P. Rockwell, H. Yuan, R. Magnusson, and M.E. Figueiredo-Pereira Proteasome inhibition in neuronal cells induces a proinflammatory response manifested by upregulation of cyclooxygenase-2, its accumulation as ubiquitin conjugates, and production of the prostaglandin PGE(2) Arch. Biochem. Biophys. 374 2000 325 333
15. J.J. Chen, W.C. Huang, and C.C. Chen Transcriptional regulation of cyclooxygenase-2 in response to proteasome inhibitors involves reactive oxygen species-mediated signaling pathway and recruitment of CCAAT/enhancer-binding protein delta and CREB-binding protein Mol. Biol. Cell 16 2005 5579 5591
16. B. Jiang, S. Xu, X. Hou, D.R. Pimentel, P. Brecher, and R.A. Cohen Temporal control of NF-kappaB activation by ERK differentially regulates interleukin-1beta-induced gene expression J. Biol. Chem. 279 2004 1323 1329
17. P. Chomczymski, and N. Sacchi Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal. Biochem. 162 1987 156 159
18. H. Inoue, C. Yokoyama, S. Hara, Y. Tone, and T. Tanabe Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells. Involvement of both nuclear factor for interleukin-6 expression site and cAMP response element J. Biol. Chem. 270 1995 24965 24971
19. G. Fenteany, R.F. Standaert, W.S. Lane, S. Choi, E.J. Corey, and S.L. Schreiber Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin Science 268 1995 726 731
20. Y.C. Chang, Y.S. Lee, T. Tejima, K. Tanaka, S. Omura, N.H. Heintz, Y. Mitsui, and J. Magae mdm2 and bax, downstream mediators of the p53 response, are degraded by the ubiquitin-proteasome pathway Cell Growth Differ. 9 1998 79 84
21. W. Xie, and H.R. Herschman Transcriptional regulation of prostaglandin synthase 2 gene expression by platelet-derived growth factor and serum J. Biol. Chem. 271 1996 31742 31748
22. 2-terminal kinase and p38 MAPK signal pathways in rat renal mesangial cells J. Biol. Chem. 273 1998 28670 28676
23. S.R. Adderley, and D.J. Fitzgerald Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases 1/2-mediated induction of cyclooxygenase-2 J. Biol. Chem. 273 1999 27686 27694
24. A. Rana, K. Gallo, P. Godowski, S. Hirai, S. Ohno, L. Zon, J.M. Kyriakis, and J. Avruch The mixed lineage kinase SPRK phosphorylates and activates the stress-activated protein kinase activator, SEK-1 J. Biol. Chem. 271 1996 19025 19028
25. Z. Yao, K. Diener, X.S. Wang, M. Zukowski, G. Matsumoto, G. Zhou, R. Mo, T. Sasaki, H. Nishina, C.C. Hui, T.H. Tan, J.P. Woodgett, and J.M. Penninger Activation of stress-activated protein kinases/c-Jun N-terminal protein kinases (SAPKs/JNKs) by a novel mitogen-activated protein kinase J. Biol. Chem. 272 1997 32378 32383
26. M. Pagano Cell cycle regulation by the ubiquitin pathway FASEB J. 11 1997 1067 1075
27. V.J. Palombella, O.J. Rando, A.L. Goldberg, and T. Maniatis The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B Cell 78 1994 773 785
28. H.M. Wu, K.H. Chi, and W.W. Lin Proteasome inhibitors stimulate activator protein-1 pathway via reactive oxygen species production FEBS Lett. 526 2002 101 105
29. T. Shibata, T. Imaizumi, W. Tamo, T. Matsumiya, M. Kumagai, X.F. Cui, H. Yoshida, S. Takaya, I. Fukuda, and K. Satoh Proteasome inhibitor MG-132 enhances the expression of interleukin-6 in human umbilical vein endothelial cells: involvement of MAP/ERK kinase Immunol. Cell Biol. 80 2002 226 230
30. J. Mezquita, B. Mezquita, M. Pau, and C. Mezquita Down-regulation of Flt-1 gene expression by the proteasome inhibitor MG262 J. Cell. Biochem. 89 2003 1138 1147
31. J.R. Mestre, K. Subbaramaiah, P.G. Sacks, S.P. Schantz, T. Tanabe, H. Inoue, and A.J. Dannenberg Retinoids suppress phorbol ester-mediated induction of cyclooxygenase-2 Cancer Res. 57 1997 1081 1085
32. J.L. Dean, M. Brook, A.R. Clark, and J. Saklatvala p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes J. Biol. Chem. 274 1999 264 269
33. W.J. Lukiw, R.P. Pelaez, J. Martinez, and N.G. Bazan Budesonide epimer R or dexamethasone selectively inhibit platelet-activating factor-induced or interleukin 1beta-induced DNA binding activity of cis-acting transcription factors and cyclooxygenase-2 gene expression in human epidermal keratinocytes Proc. Natl. Acad. Sci. USA 95 1998 3914 3919
34. Y. Kim, and S.M. Fischer Transcriptional regulation of cyclooxygenase-2 in mouse skin carcinoma cells. Regulatory role of CCAAT/enhancer-binding proteins in the differential expression of cyclooxygenase-2 in normal and neoplastic tissues J. Biol. Chem. 273 1998 27686 27694
35. M. Lasa, K.R. Mahtani, A. Finch, G. Brewer, J. Saklatvala, and A.R. Clark Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade Mol. Cell. Biol. 20 2000 4265 4274